Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Stock
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
14.9M
-
Shares change
-
+2.01M
-
Total reported value, excl. options
-
$102M
-
Value change
-
+$13.5M
-
Number of buys
-
24
-
Number of sells
-
-13
-
Price
-
$6.80
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q4 2017
52 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q4 2017.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.9M shares
.
Largest 10 shareholders include BB BIOTECH AG (2.3M shares), Prosight Management, LP (1.65M shares), FMR LLC (1.47M shares), INTERWEST VENTURE MANAGEMENT CO (1.36M shares), FRAZIER MANAGEMENT LLC (1.31M shares), Aisling Capital LLC (1.02M shares), Broadfin Capital, LLC (857K shares), GREAT POINT PARTNERS LLC (800K shares), MILLENNIUM MANAGEMENT LLC (594K shares), and Vanguard Group Inc (566K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.